{
    "code": "51058540",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058540",
    "time": "2021-12-10 06:07:54",
    "許可證字號": "衛部藥製字第058540號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/12\/04",
    "發證\/登錄日期": "103\/12\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05105854006",
    "中文品名": "太捷信膠囊250毫克(奈諾沙星)",
    "英文品名": "Taigexyn Capsule 250mg (Nemonoxacin)",
    "適應症": "「治療成人對Nemonoxacin有感受性的致病菌所引起之感染：適合於門診治療之輕度社區性肺炎。」",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒PVC\/PVDC鋁箔盒裝 4-1000粒HDPE瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "Nemonoxacin Malate Hemihydrate",
    "限制項目": "01國　產 1D須執行風險管理計畫 1E須執行Phase IV Study",
    "申請商名稱": "6201119651  太景生物科技股份有限公司",
    "申請商地址": "臺北市內湖區新明路138號7樓",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        },
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812701010",
            "成分名稱": "Nemonoxacin Malate Hemihydrate",
            "含量描述": "",
            "含量": "346.3000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡藍色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "橢圓形",
        "標記一": "TG",
        "標記二": "250"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "太捷信膠囊250毫克-藥品實體外觀-20150916上傳-104-09-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "太捷信膠囊250毫克(奈諾沙星)(衛部藥製058540號)_仿單(依西藥處方藥仿單格式)-110-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=005&Type=9"
        },
        {
            "title": "太捷信膠囊250毫克(奈諾沙星)(衛部藥製058540號)_仿單-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=004&Type=9"
        },
        {
            "title": "20190725101043066-108-07-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=003&Type=9"
        },
        {
            "title": "太捷信膠囊250毫克-2015太捷信仿單0824-Highlighted-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=002&Type=9"
        },
        {
            "title": "太捷信膠囊250毫克(奈諾沙星)(衛部藥製058540號)_外盒-110-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=007&Type=8"
        },
        {
            "title": "太捷信膠囊250毫克(奈諾沙星)(衛部藥製058540號)_外盒(中化)-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=006&Type=8"
        },
        {
            "title": "太捷信膠囊250毫克-鋁箔-20150904上傳-104-09-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058540&Seq=005&Type=8"
        }
    ]
}